Cite
Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review.
MLA
Corominas, Héctor, et al. “Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-Injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review.” Clinical Drug Investigation, vol. 43, no. 8, Aug. 2023, pp. 579–93. EBSCOhost, https://doi.org/10.1007/s40261-023-01284-5.
APA
Corominas, H., Young, D., Cummings, J. R. F., Bouhnik, Y., Armuzzi, A., Thaci, D., & Kim, J. (2023). Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. Clinical Drug Investigation, 43(8), 579–593. https://doi.org/10.1007/s40261-023-01284-5
Chicago
Corominas, Héctor, David Young, J. R. Fraser Cummings, Yoram Bouhnik, Alessandro Armuzzi, Diamant Thaci, and Jihyun Kim. 2023. “Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-Injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review.” Clinical Drug Investigation 43 (8): 579–93. doi:10.1007/s40261-023-01284-5.